创美药业股份有限公司（02289）8月18日公告称，董事会会议定于2026年8月31日（星期一）举行，主要议程包括审议并批准公司及其附属公司截至2026年6月30日止6个月的中期业绩及其发布事宜，并考虑宣派中期股息（如有）。\n\n公告显示，截至公告日期，公司执行董事为姚创龙、郑玉燕、张寒孜；非执行董事为严京斌、付征、徐飞；独立非执行董事为李汉国、尹智伟及关键（又名关苏哲）。董事会主席为严京斌。\n\n公司指出，香港交易及结算所有限公司及香港联合交易所有限公司对本公告内容概不负责，并不对其准确性或完整性作出任何声明。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.